TENAX THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
TENAX THERAPEUTICS, INC. (TENX) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $0.00 per share as of 2019-12-31, per its 10-K/A filed 2021-04-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2021-04-16
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
- 2019-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value as first filed |
|---|---|---|
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $6.29 10-K/A · filed 2021-04-16 | |
| 2018-09-30 | $6.29 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $6.28 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $0.00 10-K · filed 2020-03-30 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.72 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $54.40 10-K · filed 2019-04-01 | $2.72 10-K · filed 2017-03-16 |
| 2016-09-30 | $2.58 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $2.81 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.32 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $66.80 10-K · filed 2018-04-02 | $3.34 10-KT · filed 2016-03-14 |
| 2015-10-31 | $3.42 10-Q · filed 2015-12-10 | |
| 2015-07-31 | $3.49 10-Q · filed 2015-09-09 | |
| 2015-04-30 | $4.01 10-K · filed 2017-03-16 | |
| 2015-01-31 | $4.40 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $4.74 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $3.72 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $6.39 10-K · filed 2017-03-16 | |
| 2014-01-31 | $6.37 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $4.52 10-Q · filed 2013-12-17 | |
| 2013-07-31 | $6.82 10-Q · filed 2013-09-17 | |
| 2013-04-30 | $48.40 10-K · filed 2017-03-16 | |
| 2013-01-31 | $1.77 10-Q · filed 2013-03-18 | |
| 2012-10-31 | $1.83 10-Q · filed 2012-12-14 | |
| 2012-07-31 | $1.84 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $43.80 10-KT · filed 2016-03-14 | $2.19 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |